Organization Overview
Alternative names
bevacizumab (avastin) (15 trials)
capecitabine (xeloda) (9 trials)
carboplatin (paraplatin) (8 trials)
epirubicin (ellence) (8 trials)
erlotinib (tarceva) (4 trials)
fluorouracil (efudex) (8 trials)
Breast Neoplasms (Phase 3)
Carcinoma, Non-Small-Cell Lung (Phase 3)
Carcinoma, Ovarian Epithelial (Phase 2)
Colonic Neoplasms (Phase 3)
Colorectal Neoplasms (Phase 3)
Lung Neoplasms (Phase 3)
Ovarian Neoplasms (Phase 2)
Pancreatic Neoplasms (Phase 2)
Small Cell Lung Carcinoma (Phase 2)
Stomach Neoplasms (Phase 2)
Urinary Bladder Neoplasms (Phase 2)